<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>
  <GBSeq_locus>E03756</GBSeq_locus>
  <GBSeq_length>589</GBSeq_length>
  <GBSeq_strandedness>single</GBSeq_strandedness>
  <GBSeq_moltype>RNA</GBSeq_moltype>
  <GBSeq_topology>linear</GBSeq_topology>
  <GBSeq_division>PAT</GBSeq_division>
  <GBSeq_update-date>04-NOV-2005</GBSeq_update-date>
  <GBSeq_create-date>06-JUN-1997</GBSeq_create-date>
  <GBSeq_definition>DNA encoding hepatitis C virus antigenic peptide</GBSeq_definition>
  <GBSeq_primary-accession>E03756</GBSeq_primary-accession>
  <GBSeq_accession-version>E03756.1</GBSeq_accession-version>
  <GBSeq_other-seqids>
    <GBSeqid>dbj|E03756.1|</GBSeqid>
    <GBSeqid>pat|JP|1992179482|12</GBSeqid>
    <GBSeqid>gi|2171971</GBSeqid>
  </GBSeq_other-seqids>
  <GBSeq_keywords>
    <GBKeyword>JP 1992179482-A/12</GBKeyword>
  </GBSeq_keywords>
  <GBSeq_source>Hepatitis C virus</GBSeq_source>
  <GBSeq_organism>Hepatitis C virus</GBSeq_organism>
  <GBSeq_taxonomy>Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage; Flaviviridae; Hepacivirus</GBSeq_taxonomy>
  <GBSeq_references>
    <GBReference>
      <GBReference_reference>1</GBReference_reference>
      <GBReference_position>1..589</GBReference_position>
      <GBReference_authors>
        <GBAuthor>Shimotoono,K.</GBAuthor>
        <GBAuthor>Kato,N.</GBAuthor>
        <GBAuthor>Hijikata,M.</GBAuthor>
        <GBAuthor>Nakagawa,M.</GBAuthor>
        <GBAuthor>Kunai,K.</GBAuthor>
        <GBAuthor>Okada,M.</GBAuthor>
      </GBReference_authors>
      <GBReference_title>GENE DERIVED FROM HEPATITIS C VIRUS</GBReference_title>
      <GBReference_journal>Patent: JP 1992179482-A 12 26-JUN-1992; SHIMOTOONO KUNITADA, TOKUYAMA SODA CO LTD</GBReference_journal>
    </GBReference>
  </GBSeq_references>
  <GBSeq_comment>OS Hepatitis C virus~PN JP 1992179482-A/12~PD 26-JUN-1992~PF 11-NOV-1990 JP 1990304417~PI SHIMOTOONO KUNITADA, KATO NORIYUKI, HIJIKATA MAKOTO, PI NAKAGAWA MASANORI,~PI KUNAI KENJI, OKADA MASATO~PC C12N15/51,C07K13/00,C12N1/21,C12P21/02//G01N33/576,(C12N1/21, PC C12R1:19),~PC (C12P21/02,C12R1:19);~CC strandedness: Double;~CC topology: Linear;~FH Key Location/Qualifiers~FH~FT misc_feature 1..589~FT /product="antigenic peptide of hepatitis C FT virus"</GBSeq_comment>
  <GBSeq_feature-table>
    <GBFeature>
      <GBFeature_key>source</GBFeature_key>
      <GBFeature_location>1..589</GBFeature_location>
      <GBFeature_intervals>
        <GBInterval>
          <GBInterval_from>1</GBInterval_from>
          <GBInterval_to>589</GBInterval_to>
          <GBInterval_accession>E03756.1</GBInterval_accession>
        </GBInterval>
      </GBFeature_intervals>
      <GBFeature_quals>
        <GBQualifier>
          <GBQualifier_name>organism</GBQualifier_name>
          <GBQualifier_value>Hepatitis C virus</GBQualifier_value>
        </GBQualifier>
        <GBQualifier>
          <GBQualifier_name>mol_type</GBQualifier_name>
          <GBQualifier_value>unassigned RNA</GBQualifier_value>
        </GBQualifier>
        <GBQualifier>
          <GBQualifier_name>db_xref</GBQualifier_name>
          <GBQualifier_value>taxon:11103</GBQualifier_value>
        </GBQualifier>
      </GBFeature_quals>
    </GBFeature>
  </GBSeq_feature-table>
  <GBSeq_sequence>agggggctgtgcagtggatgaaccggctgatagcgttcgcttcgcggggtaaccacgtctcccccacgcactatgtgcccgagagcgacgccgcggcgcgtgttactcagatcctctccagccttaccatcactcagttgctgaagaggcttcatcagtggattaatgaggactgctccacgccttgttccggctcgtggctaaaggatgtttgggactggatatgcacggtgttgagtgacttcaagacttggctccagtccaagctcctgccgcggttaccgggactccctttcctgtcatgccaacgcgggtacaagggagtctggcggggggatggcatcatgcaaaccacctgcccatgtggagcacagatcaccggacatgtcaaaaatggctccatgaggattgttgggccaaaaacctgcagcaacacgtggcatggaacattccccatcaacgcatacaccacgggcccctgcacgccctccccagcgccgaactattccagggcgctgtggcgggtggctgctgaggagtacgtggaggttacgcgggtgggggatttccactacgtgacgggcatgac</GBSeq_sequence>
</GBSeq>
